BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BPC 157 Ligament: 1 Unsafe Truth FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures KTLA Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law